These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29449336)

  • 1. Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.
    Mackman N; Spronk HMH; Stouffer GA; Ten Cate H
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):726-732. PubMed ID: 29449336
    [No Abstract]   [Full Text] [Related]  

  • 2. More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions.
    Spinthakis N; Farag M; Rocca B; Gorog DA
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374045
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary and peripheral artery atherosclerosis: what choice for antiplatelet therapy.
    Gresele P
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e72-e74. PubMed ID: 29538147
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic therapy in peripheral artery disease.
    Foley TR; Waldo SW; Armstrong EJ
    Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic Therapy in Lower Extremity Artery Disease.
    Vrsalovic M; Aboyans V
    Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulation and antiplatelet therapy in patients with peripheral arterial disease of the femoropopliteal arteries.
    Vos CG; Vahl AC
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):164-171. PubMed ID: 28933520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic Therapy for Peripheral Revascularisation.
    De Carlo M; Angelillis M; Liga R
    Curr Vasc Pharmacol; 2020; 18(3):223-236. PubMed ID: 30727899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials.
    Bauersachs R; Wu O; Briere JB; Bowrin K; Borkowska K; Jakubowska A; Taieb V; Toumi M; Huelsebeck M
    Cardiovasc Ther; 2020; 2020():3057168. PubMed ID: 32695228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotics in stable peripheral artery disease.
    Kaplovitch E; Rannelli L; Anand SS
    Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
    Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is heparin an acceptable anticoagulant when glycoprotein IIb/IIIa inhibitors are not used?
    Lee MS; Rha SW; Park KW; Kim MH
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):223-224. PubMed ID: 25616929
    [No Abstract]   [Full Text] [Related]  

  • 15. Bibliography--Editors' selection of current world literature.
    Coron Artery Dis; 2013 Jan; 24(1):69-73. PubMed ID: 23222214
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic influence of rivaroxaban on inflammation and coagulation biomarkers in patients with coronary artery disease and peripheral artery disease on aspirin therapy.
    Tantry U; Cummings C; Mackrell P; Gonze M; Ulloa K; Bafford R; Rout A; Sukhi A; Gurbel P
    Future Cardiol; 2020 Mar; 16(2):69-75. PubMed ID: 32129681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Double and Triple Therapy with Direct Oral Anticoagulants in Coronary Artery Disease, Peripheral Artery Disease, and Stroke.
    Romero N; Lupi K; Carter D; Malloy R
    Clin Ther; 2018 Nov; 40(11):1907-1917.e3. PubMed ID: 30458931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging clinical setting of direct oral anticoagulants: atherothrombotic events prevention.
    Di Fusco SA; Lucà F; Gulizia MM; Gabrielli D; Colivicchi F
    J Cardiovasc Med (Hagerstown); 2020 Jan; 21(1):1-5. PubMed ID: 31688432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.
    Lettino M; Leonardi S; De Maria E; Halvorsen S
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):61-70. PubMed ID: 28618904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.